D
Dorien H. Nieman
Researcher at University of Amsterdam
Publications - 119
Citations - 4685
Dorien H. Nieman is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Population & Schizophrenia. The author has an hindex of 33, co-authored 112 publications receiving 3754 citations.
Papers
More filters
Journal ArticleDOI
Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification
Paolo Fusar-Poli,Paolo Fusar-Poli,Marco Cappucciati,Marco Cappucciati,Stefan Borgwardt,Scott W. Woods,Jean Addington,Barnaby Nelson,Dorien H. Nieman,Daniel Stahl,Grazia Rutigliano,Anita Riecher-Rössler,Andor E. Simon,Masafumi Mizuno,Tae Young Lee,Jun Soo Kwon,May M.L. Lam,Jesus Perez,Szabolcs Kéri,Paul Amminger,Sibylle Metzler,Wolfram Kawohl,Wulf Rössler,Jimmy Lee,Javier Labad,Tim Ziermans,Suk Kyoon An,Chen-Chung Liu,Kristen A. Woodberry,Kristen A. Woodberry,Amel Braham,Cheryl Corcoran,Patrick D. McGorry,Alison R. Yung,Philip McGuire +34 more
TL;DR: There is meta-analytical evidence that BLIPS represents separate risk subgroup compared with the APS and GRD and there was no evidence that the GRD subgroup has a higher risk of psychosis than the CHR- subgroup.
Journal ArticleDOI
The Validity of the 16-Item Version of the Prodromal Questionnaire (PQ-16) to Screen for Ultra High Risk of Developing Psychosis in the General Help-Seeking Population
Helga K. Ising,Wim Veling,Rachel Loewy,Marleen W. Rietveld,Judith Rietdijk,Sara Dragt,Rianne M. C. Klaassen,Dorien H. Nieman,Lex Wunderink,Don H. Linszen,Mark van der Gaag +10 more
TL;DR: The PQ-16 is a good self-report screen for use in secondary mental health care services to select subjects for interviewing for psychosis risk, the low number of items makes it quite appropriate for screening large help-seeking populations, thus enhancing the feasibility of detection and treatment of ultra high-risk patients in routine mental health services.
Journal ArticleDOI
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention
Paolo Fusar-Poli,Gonzalo Salazar de Pablo,Gonzalo Salazar de Pablo,Christoph U. Correll,Andreas Meyer-Lindenberg,Millan Mark,Stefan Borgwardt,Stefan Borgwardt,Silvana Galderisi,Andreas Bechdolf,Andrea Pfennig,Lars Vedel Kessing,Therese van Amelsvoort,Dorien H. Nieman,Katharina Domschke,Marie-Odile Krebs,Nikolaos Koutsouleris,Nikolaos Koutsouleris,Philip McGuire,Philip McGuire,Kim Q. Do,Celso Arango +21 more
TL;DR: This review confirmed recent substantial advancements in the detection and prognosis of CHR-P individuals while suggesting that effective indicated interventions need to be identified and needs-based and psychological interventions should still be offered.
Journal ArticleDOI
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
Patrick D. McGorry,Barnaby Nelson,Connie Markulev,Hok Pan Yuen,Miriam R. Schäfer,Nilufar Mossaheb,Monika Schlögelhofer,S. Smesny,Ian B. Hickie,Gregor Berger,Eric Y.H. Chen,Lieuwe de Haan,Dorien H. Nieman,Merete Nordentoft,Anita Riecher-Rössler,Swapna Verma,Andrew Thompson,Alison R. Yung,Paul Amminger +18 more
TL;DR: This trial clearly failed to replicate the findings of the original single-center trial, and the main conclusion is that &ohgr;-3 PUFAs are not effective under conditions where good quality, evidence-based psychosocial treatment is available.
Journal ArticleDOI
Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
Eva Velthorst,Dorien H. Nieman,Hiske E. Becker,Reinaud van de Fliert,Peter Dingemans,Rianne M. C. Klaassen,Lieuwe de Haan,Therese van Amelsvoort,Don H. Linszen +8 more
TL;DR: This study indicates that severity of specific symptoms at baseline is related to transition to psychosis in UHR subjects, which may contribute to a more accurate prediction of a first psychotic episode.